[CH3:1][C:2]1[N:3]=[C:4]([NH:19][C:20](=[O:22])[CH3:21])[S:5][C:6]=1[C:7]1[CH:12]=[CH:11][N:10]=[C:9](N2CCOCC2)[N:8]=1.Cl.[C:24](N)(=N)[CH:25](C)[CH3:26]>>[CH:25]([C:9]1[N:8]=[C:7]([C:6]2[S:5][C:4]([NH:19][C:20](=[O:22])[CH3:21])=[N:3][C:2]=2[CH3:1])[CH:12]=[CH:11][N:10]=1)([CH3:26])[CH3:24]The titled compound is prepared by an analogous procedure to N-[4-Methyl-5-(2-morpholin-4-yl-pyrimidin-4-yl)-thiazol-2-yl]-acetamide (25e) by replacing morpholinoformamidine hydrobromide (part 25c) with isobutyramidine hydrochloride.